Family · Pharmaceutical analytical standards
Sulpiride
An antipsychotic of the benzamide family, discovered in France in 1966, that selectively blocks dopamine D2 and D3 receptors: it is used for schizophrenia and, at low doses, for dysthymia and mild depression. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.
Did you know?It came from research on something else entirely: Justin-Besançon and Laville were trying to improve the antiarrhythmic properties of procainamide, and got an antipsychotic instead.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
